Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Breathing difficult; Fever; tiredness; This is a spontaneous report from a contactable nurse downloaded from the Regulatory Authority, Regulatory Authority number SE-MPA-2021-003068. Other case identifier number SE-MPA-1612791403816. A 47-year-old female patient received the first dose of bnt162b2 (COMIRNATY) (Batch/lot number: EJ6134) intramuscularly in Jan2021 at 0.3ml single for COVID-19 immunisation. Medical history included congenital oesophageal anomaly, respiratory congenital anomaly, chronic obstructive pulmonary disease, pulmonary fibrosis, attention deficit hyperactivity disorder (ADHD), Asperger''s disorder, hepatitis C, right ventricular failure, all unknown if ongoing. Concomitant medications were not reported (Current medication list was missing). Patient developed fever and breathing difficult in Feb2021. According to the reporting nurse the woman (patient), five days after the vaccination with Comirnaty, developed tiredness, fever (38 degrees) and difficulty breathing in Feb2021. The woman herself called an ambulance, she was given Alvedon and Ventoline and booked an appointment at the health center the following day. The next morning, the woman was found dead on the floor of her home (Feb2021). It was not reported if an autopsy was performed. Report assessed the events as serious, Death.; Reported Cause(s) of Death: Breathing difficult; Fever; tiredness
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166